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Abstract
Background: Tobacco smoking remains the leading preventable cause of death among American women. Exercise 
has shown promise as an aid to smoking cessation because it reduces weight gain and weight concerns, improves 
affect, and reduces nicotine withdrawal symptoms and cigarette craving. Studies have shown that the practice of yoga 
improves weight control, and reduces perceived stress and negative affect. Yoga practice also includes regulation of 
breathing and focused attention, both of which may enhance stress reduction and improve mood and well-being and 
may improve cessation outcomes.
Methods/Design: This pilot efficacy study is designed to examine the rates of cessation among women randomized 
to either a novel, 8-week Yoga plus Cognitive Behavioral Therapy (CBT) smoking cessation intervention versus a 
Wellness program plus the same CBT smoking cessation intervention. Outcome measures include 7-day point 
prevalence abstinence at end of treatment, 3 and 6 months follow up and potential mediating variables (e.g., 
confidence in quitting smoking, self-efficacy). Other assessments include measures of mindfulness, spirituality, 
depressive symptoms, anxiety and perceived health (SF-36).
Discussion: Innovative treatments are needed that address barriers to successful smoking cessation among men and 
women. The design chosen for this study will allow us to explore potential mediators of intervention efficacy so that 
we may better understand the mechanism(s) by which yoga may act as an effective complementary treatment for 
smoking cessation. If shown to be effective, yoga can offer an alternative to traditional exercise for reducing negative 
symptoms that often accompany smoking cessation and predict relapse to smoking among recent quitters.
Trial Registration: ClinicalTrials NCT00492310
Background
Over 17% of adult women in the United States are current
smokers [1]. Tobacco smoking remains the leading pre-
ventable cause of death among American women and is a
major cause of heart disease, lung and other cancers and
many other illnesses [2]. Despite the importance of quit-
ting, smokers encounter a number of significant barriers
when they try to quit including nicotine addiction and its
associated withdrawal symptoms, cigarette craving,
increased negative affect, perceived stress, and post-ces-
sation weight gain [3-6].
Aside from making quitting smoking uncomfortable,
t h e s e  s y m p t o m s  a l s o  i n c r e a s e  t h e  i n d i v i d u a l ' s  r i s k  f o r
relapse to smoking. Perceived stress, negative affect, and
the severity of withdrawal symptoms have all been shown
to predict time to relapse among recent ex-smokers [5-7].
P o s t - c e s s a t i o n  w e i g h t  g a i n  a n d  f e a r  o f  w e i g h t  g a i n  a r e
common among smokers. They often constitute a sub-
stantial barrier to initial cessation and are independent
predictors of relapse to smoking, particularly among
women [8-11]. Therapies that provide alternative meth-
ods to cope with withdrawal symptoms, negative affect,
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stress and concerns regarding weight gain should
improve women's ability to quit and remain quit.
Exercise has been proposed as an aid to smoking cessa-
tion for women because of its ability to help offset weight
gain during cessation and to reduce concern regarding
weight gain [12,13]. Because exercise improves affect in
adult populations [14-20], exercise may also aid cessation
by reducing negative affect and withdrawal symptoms
[21,12]. Previous studies have demonstrated that a tradi-
tional aerobic exercise program (i.e., brisk walking, bicy-
cling) combined with Cognitive-Behavioral Therapy
(CBT) produces higher quit rates among women at post-
treatment and six-month follow up compared to CBT
without exercise [12,22].
Yoga is an alternative to traditional (western) exercise
that has potential as a complementary treatment for
smoking cessation. Yoga is comprised of several elements
including regulation of breathing, asanas (yoga postures),
and focused attention (e.g., meditation), all of which may
enhance stress reduction and improve mood and well-
being [23], which are linked to successful smoking cessa-
tion [24]. Several studies have shown that the practice of
yoga improves weight control [25-28], and reduces per-
ceived stress and negative affect [29-32]. Based on a syn-
thesis of this evidence-based research, this study is
designed to examine the effects of an 8-week yoga pro-
gram on perceived stress, affect, and the process of quit-
ting smoking among healthy, adult women smokers.
Methods/Design
Design
The study design is a randomized, controlled pilot study
comparing two conditions: 1) group-based cognitive-
behavioral therapy (CBT) for smoking cessation plus a
twice-weekly group-based yoga program (Yoga); and 2)
CBT for smoking cessation plus a group-based wellness
program that serves as a contact-control (Wellness).
Groups of 8-10 individuals enter the program in sequen-
tial cohorts and participate in the 8-week treatment pro-
gram. Assessments take place at baseline (before program
entry), end-of-treatment (week 8), and both 3 and 6
months follow up.
Participant recruitment
Recruitment methods include placing advertisements in
local newspapers and websites, posting flyers and placing
brochures at commercial locations (e.g., convenience
stores, grocery stores) and physician's offices, and televi-
sion coverage. The study research assistant (RA) is
trained to provide information about the program to
women who call the program in response to the adver-
tisements, and to screen interested persons for eligibility.
Callers are excluded if they smoke less than 5 cigarettes
per day, are already physically active (> 3 days of moder-
ate-intensity physical activity or >2 days vigorous inten-
sity exercise per week); are currently practicing yoga,
have current heart disease, lung disease, or orthopedic
conditions that could make participation in yoga difficult
or dangerous; or are currently in treatment for psychiat-
ric illness or are using illegal substances. Eligible partici-
pants are also screened to ensure safe participation in
physical activity by using the PAR-Q [33], and are sent a
letter for their physician to sign giving permission to par-
ticipate in the program. Individuals deemed eligible fol-
lowing screening are then scheduled for an introductory
orientation session during which the study RA presents
the details of the study, reviews what is required of partic-
ipants and administers informed consent. All recruitment
procedures and materials including advertisements, con-
sent forms and procedures are approved by the Miriam
Hospital Clinical Research Review Board (IRB registra-
tion # 0000482).
Procedures
Enrolled participants are randomly assigned to either the
yoga or wellness arms of the study. All participants are
also provided on a weekly basis with 1-hour of group
based CBT for smoking cessation (separate groups are
held for yoga and wellness participants). One yoga and
one wellness session per week are scheduled for the same
night as the smoking group treatment, so that partici-
pants need to travel to the program only two evenings per
week.
Interventions
Yoga classes are conducted twice weekly for eight consec-
utive weeks by certified yoga instructors with over 15
years experience and who are trained in the Vinyasa style.
Vinyasa is a form of Hatha yoga that emphasizes the con-
tinuous flow of movement between postures (asanas)
and links breath with the movements. In collaboration
with the researchers, yoga instructors select a pattern of
asanas that are appropriate for beginners and teach them
consistently during each class. Each class consists of five
minutes of breathing exercises (pranayama) and seated
meditation, followed by 45 minutes of dynamically linked
asanas (see Figure 1). Classes conclude with ten minutes
of closing postures (similar to the "cooling down" period
following aerobic exercise) and a final seated meditation.
Participants attending the wellness sessions are shown
videos regarding a variety of health topics (e.g., low fat
diets, breast cancer screenings, back health) followed by a
discussion guided by the study RA and distribution of
written material relevant to the video topic.
The CBT smoking cessation program is lead by a PhD
psychologist with over 10 years experience in conducting
smoking cessation groups. Treatment is delivered
through use of a program manual to ensure consistentBock et al. BMC Complementary and Alternative Medicine 2010, 10:14
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delivery of program content. Topics include self-monitor-
ing, stimulus control, coping with high-risk situations,
and stress management for smoking cessation. The pro-
gram also focuses on topics of concern to women when
quitting including: healthy eating, weight management,
and balancing multiple roles and multiple demands. This
program has been used in our prior studies [12,22]. Par-
ticipants are also encouraged to select healthy, low-calo-
rie snacks throughout the program and are provided with
examples of these snacks to sample. Participants are not
provided with nicotine replacement therapy (NRT) or
other smoking cessation medications, but are allowed to
use them in conjunction with the program, if their pri-
mary care physician deems it advisable.
Measures
Participants complete assessments at baseline, end of
treatment (week 8), and both 3 and 6 month follow up
(see Table 1). Assessment instruments include surveys of
demographic variables, smoking history and nicotine
dependence [34] (FTND), Smoking Situations Tempta-
tions scale [35](SST), Stage of Change for Smoking Ces-
sation [36], the Smoking Self-efficacy scale [35] (SSE),
Withdrawal Symptoms Checklist [37]; and a single item
assessing confidence for achieving smoking cessation.
Participants also complete the Freiberg Mindfulness
Inventory [38] (FMI), and measures of spirituality [39]
(STI); [40,41] Anxiety (STAIT); and depressive symptoms
[42](CESD-10). Participants also complete assessments of
exercise participation [43,44] (PAR), Physical Self-Percep-
tion Profile [45] (PSPP); the Short-Form Health Survey
[46] (SF-36), and assessments of concern regarding post-
cessation weight gain [47] (SSQ).
E a c h  w e e k  d u r i n g  t h e  p r o g r a m ,  p a r t i c i p a n t s  a r e
assessed for current smoking status (verified by exhaled
carbon monoxide [CO]). To assess for acute changes, cur-
rent positive and negative affect [48] (PANAS), nicotine
withdrawal symptoms and cigarette craving are measured
once weekly pre- and post-session (yoga or wellness).
Smoking outcomes (7-day point prevalence abstinence)
are biochemically validated by exhaled carbon monoxide
(cutoff < 10 ppm) and saliva cotinine (cutoff = 15 mg/
ml)[49].
At the end of each cohort, separate focus groups are to
be held for the yoga and wellness participants. Focus
Figure 1 Basic Vinyasa Yoga Asanas.
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groups are conducted by a PhD Psychologist with over 10
years experience in leading focus groups and conducting
qualitative research. Focus groups discuss acceptability of
the study protocols and intervention components. In par-
ticular, discussions explore participant opinions and
observations regarding the intervention content, pro-
gram format, and study design (e.g., program length, tim-
ing of sessions, and the number of classes per week). Each
of these questions is addressed primarily from the stand-
point of the individual participant's experience with the
program. A qualitative data collection guide was pre-
pared by the investigators to delineate topics and subtop-
ics to be addressed during the focus group discussions.
Each focus group requires approximately 2 hours to be
completed, and is audio taped and professionally tran-
scribed for analysis.
Outcomes
The primary outcomes for this study are post-treatment
cessation rates, study feasibility and acceptability. Differ-
ences in post-treatment (12 week) cessation rates
between conditions will provide data for estimates of
effect size necessary to calculate power estimates for a
major clinical trial. The qualitative and quantitative feasi-
bility and acceptability of the Quitting in Balance pro-
gram will be assessed by the following outcome measures
at the individual participant level:
1. Smoking abstinence rates
2. Accrual and Retention rates
3. Acceptance of Randomization
4. Compliance with study protocol
The feasibility and acceptability outcome measures
listed above will be assessed at baseline, 12-weeks (end of
treatment), and 3 and 6 months follow-up.
Table 1: Measurement Schedule
Measure Baseline weeks
1-8
Post-
treatment
Month
3
Month
6
Demographics ?
Smoking Status
Smoking History ?
Nicotine dependence [34]
Smoking Behavior, Carbon 
monoxide
?????
Saliva Cotinine [49] ? ? ?
W i t h d r a w a l  S y m p t o m s , [ 3 7 ] ?????
Physical Activity Status
7-Day PAR [43,44] ? ? ? ?
PARQ [33] ?
Weight concerns
Weight Concerns [47] ? ? ? ?
Psychosocial Measures
Self-efficacy, Stage of 
Change [35,36]
?? ? ?
Mindfulness [38] ? ? ? ?
Spirituality [39]
Depression [42] ? ? ? ?
Anxiety [40,41]
Physical Self-perception [45] ? ? ? ?
Short form health survey [46]
Mood (PANAS) [48] ?
Cigarette craving
Recruitment, Retention and Satisfaction Measures
Attendance and drop out ? ?
Group Cohesion ?
Consumer Satisfaction ?Bock et al. BMC Complementary and Alternative Medicine 2010, 10:14
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Sample size
The nature of this innovative exploratory treatment study
necessarily provides limits on the effective sample size,
limiting the number of smokers that can be recruited,
complete instruments, and participate in the interven-
tion. There is not yet sufficient information to estimate a
potential treatment effect size for the CBT + Yoga condi-
tion. Thus, our primary interest was to determine a valid
estimate of the yoga intervention effect size for smoking
cessation for a future, larger efficacy trial. Consequently,
we did not conduct power analysis calculations. Rather,
the required sample size was based on the number of par-
ticipants needed to perform valid estimates of the CBT +
Yoga intervention smoking cessation rate and possible
differential smoking cessation rates between treatments.
Given the typical differences in quit rates in most smok-
ing cessation studies, often 10%-15%, [12,22,48,50], we
determined that a sample size of 60 participants would be
sufficient to obtain initial estimates of effect size with
60% power (medium effect size).
Randomization
After attending an initial Orientation session, in which
the study and its requirements will be explained and par-
ticipants have provided written consent, participants will
be randomly assigned to one of the two investigational
conditions. Randomization will be conducted the first
evening of the program with all participants present
using a simple randomization protocol.
Blinding
Because of the nature of the study, it is not possible to
blind participants or the study counselors to condition.
Smoking cessation therapy will be offered in a group set-
ting during which time participants often remark on the
content of the yoga or wellness program. Research assis-
tants who conduct all assessments will be blind to study
condition.
Implementation
Adult women smokers who are seeking treatment for
quitting smoking will be recruited through advertise-
ments in local newspapers, flyers at grocery stores and
Internet advertisements. Participants will be included in
the trial if they meet inclusion criteria and have signed
informed consent. To ensure the implementation of the
intervention, quality audits will be conducted. A PhD cli-
nician will listen to audio tapes of 50% of all group CBT
sessions and use an objective ratings sheet to record the
quality of coverage for all planned topics listed in the
treatment manual.
Time Plan
The development of this program began in August of
2007 and was finished in December 2007. Participant
recruitment started in January, 2008 and continued
through May 2009. The trial will be completed in June
2010.
Planned Analyses
The primary outcome variable is quit status, verified with
carbon monoxide (cutoff, 8 ppm) weekly, and with saliva
cotinine (cutoff, 15 ng/ml) at the end of treatment, and
both 3 and 6 month follow up assessments [49]. To be
considered abstinent, subjects need to have a carbon
monoxide level less than 8 ppm and a cotinine level less
than 57 nmol/L [15 ng/mL].
The primary hypothesis of the study will be tested
using a logistic regression to produce an odds ratio mea-
suring the effect of CBT + Yoga on the likelihood of
smoking cessation at the post-treatment and follow up
assessments. The intention-to-treat principle will be used
to calculate treatment effects and differences using all
participants initially assigned to treatment. Analyses will
also include calculations of the proportion of participants
who are continuously abstinent, and abstinent as assessed
for 7-day point-prevalence for both treatment groups in
order to provide a fuller estimate and understanding of
the possible range of the treatment effects. In addition,
we will conduct a second longitudinal analysis across
time (end of treatment, 3 and 6 month follow up after
treatment) using the generalized estimating equations
(GEE) approach of Zeger and Liang [51]. This procedure
can accommodate covariates and missing data, thus
allowing the maximum use of existing data (and thus
enhanced power) for detecting treatment effects. This
approach is also highly flexible for modeling trend analy-
ses that allow for an alternate way to present intervention
effectiveness (comparing trends in both groups over
time).
Secondary analyses will examine the effects of yoga on
other psychological and behavioral domains including
anxiety, quality of life, spirituality, mindfulness and self-
esteem. These analyses will consist of a series of repeated
measures analyses of covariance using the baseline mea-
sure of each variable as a covariate and 3 repeated mea-
surements (end of treatment, 3 and 6 month follow up).
Further analyses will examine the effects of the CBT +
Yoga intervention on potential mediators of smoking
behavior change, and the relationships of the potential
mediators to smoking cessation. The potential mediators
of interest include changes in affect, perceived stress, well
being, and self-efficacy as well as cigarette craving and
withdrawal symptoms. We will also examine for any dif-
ferences in the effects of the CBT + Yoga intervention
versus the CBT + Wellness intervention on these inter-
mediate variables. Given the limited sample size in the
proposed study, these analyses will be exploratory in
nature, and within the context of these analyses, we willBock et al. BMC Complementary and Alternative Medicine 2010, 10:14
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be trying to establish 2 of the 3 key directional effects
needed to describe potential mediators as noted by Baron
and Kenny [52], that is we will be investigating which of
the potential mediating variables are affected by the treat-
ment, and which of these potential mediators are also
related to the key smoking cessation outcome variables.
The strongest evidence for mediation is time-ordered,
and these analyses will examine the effects of treatment
on each of the various potential mediating variables at
immediate post-treatment (8 week assessment), and
include analyses of possible longitudinal treatment effects
extending to the 3 and 6 month follow up. These analyses
will consist of a series of repeated measures analyses of
covariance using the baseline measure of each potential
mediator variable as a covariate and 3 repeated measure-
ments (end of treatment, 3 and 6 month follow up). We
will conduct these analyses using Proc MIXED in SAS,
which will allow us to easily conduct contrast tests to
compare both between and within group effects across
time. Proc MIXED also accommodates missing values
under the assumption of missing at random [53], and will
allow us to make maximum use of the existing data to
detect treatment effects. To examine the effects of poten-
tial mediator variables on treatment outcome we will
conduct a series of time-ordered logistic regressions,
(e.g., post-treatment value of smoking self-efficacy, per-
ceived stress and well-being, etc. predicting both contin-
uous abstinence and 7-day point prevalence at 3-month
follow-up).
Lastly, we will conduct qualitative analysis of the focus
group material for common and emergent themes
emphasizing aspects of the program that participants
liked most and least, along with their suggestions for
changes. Data will be coded by themes derived from the
focus group guide and managed using NVivo qualitative
data software. The range of participant opinions, experi-
ences and observations will be summarized and inter-
preted as feedback for consideration in revising future
iterations of the intervention.
Analyses of Baseline Data
The baseline demographic, psychosocial, and smoking-
related characteristics of the study participants are
described here using means, standard deviations, range
values and proportions. Stage of Change for Smoking
Cessation is calculated in two ways, with the first based
solely on intention to quit, while the second classifies par-
ticipants into the Preparation stage if they both intend to
quit in the next 30 days and they have made at least 1 quit
attempt (≥24 hr) in the past year. To describe participant's
experience with withdrawal symptoms during previous
quit attempts we calculated the percentage of the sample
that endorsed 3 or higher on the Withdrawal Symptoms
checklist [37] (scored from 1 = "not at all' to 5 =
"extremely"), which assessed the severity of nicotine with-
drawal symptoms.
Discussion
If shown to be effective, yoga can offer an alternative to
traditional exercise for reducing negative symptoms that
often accompany smoking cessation and predict relapse
to smoking among recent quitters. Yoga may enhance the
effects of CBT by providing an alternate method for cop-
ing with stress and cigarette cravings, and may be associ-
ated with improvements in mood and quality of life. Yoga
is intended to be a lifelong practice that can potentially
reinforce quitting smoking once formal smoking treat-
ment ends.
In addition to making quitting smoking uncomfortable,
symptoms including perceived stress, negative affect and
the overall severity of withdrawal symptoms have all been
shown to increase the individual's risk for relapse to
smoking. Relapse to smoking within the first week of
quitting is preceded by increases in withdrawal symp-
toms, including craving for cigarettes, distress, and
reductions in positive affect [54]. Perceived stress and
negative affect have also been shown to predict time to
relapse among recent ex-smokers [5,6,55,56]. Providing
smokers with methods of coping with stress should
improve their ability to quit and remain quit [57].
Several studies have documented that traditional (west-
ern) aerobic exercise improves smoking cessation among
women [12,22,58]. Vinyasa yoga, which includes both
aerobic exercise as well as other features such as focused
attention and deliberate regulation of breathing, may be
especially beneficial to women who are trying to quit
smoking. The goal of this study is to examine the utility of
a program of yoga as a complementary treatment to cog-
nitive-behavioral therapy for smoking cessation.
This study is an initial investigation of the efficacy of
yoga as a complementary treatment for smoking cessa-
tion among women. While our prior studies used a 12-
week treatment protocol to ensure that changes in physi-
cal fitness could be measured, we chose to deliver treat-
m e n t  o v e r  8  w e e ks.  T h i s  c h o i c e  w a s  m a d e  f o r  s e v e r a l
reasons. First, the effects of exercise on mood and ciga-
rette craving seen in our previous study [21] were acute,
rather than chronic-training effects. Thus, it seems likely
that the effects of yoga practice on these symptoms would
also be produced acutely. The 12-week protocol used in
our other studies was chosen to allow sufficient time for
fitness changes to take place. Since we were not hypothe-
sizing that fitness changes were responsible for the effect
of yoga on smoking cessation, measuring a training effect
was deemed unnecessary. Second, the use of a shorter
overall treatment program reduces subject burden and is
likely to lower the risk of dropout. Third, participants in
our previous studies were very unlikely to make an initialBock et al. BMC Complementary and Alternative Medicine 2010, 10:14
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quit after week 8, therefore extending CBT beyond week
8 seemed unlikely to increase treatment effectiveness.
Another design choice made in developing this study was
the use of a Health & Wellness program as a comparison
condition. An alternative design would have been to test
CBT alone (with no adjunctive program) compared to
CBT plus yoga. In some ways, the second option would
have provided a more "real world" comparison, in that the
use of yoga with CBT does add additional time and treat-
ment burden to quitting smoking. However, we chose to
use the Healthy & Wellness program to control for the
amount of time participants were in contact with the
research staff (contact-control) and to equalize subject
burden. Last, because this is an initial study of the poten-
tial for using yoga as a complementary therapy in smok-
ing cessation, we also chose to use a variety of measures
of affect, self-perception and experiential variables (e.g.,
FMI assessment of mindfulness). The design chosen for
this study will allow us to explore potential mediators of
intervention efficacy so that we may better understand
the mechanism(s) by which yoga may act as an effective
complementary treatment for smoking cessation.
Innovative treatments are needed that address barriers
to successful smoking cessation among men and women.
The practice of yoga has been linked to improvements in
affect, reductions in stress and anxiety, increases in self-
efficacy and improvements in overall well-being in addi-
tion to producing improvements in cardiopulmonary
functioning [29-32]. Therefore, yoga may prove to be a
more effective complementary treatment for smoking
cessation than traditional aerobic exercise.
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